Fast Locator 2013-2014: MPI Research - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2013-2014: MPI Research


Untitled Document

MPI Research
54943 North Main Street
Mattawan, MI 49071

Regions served:
Asia
North America
Europe

Description:
MPI RESEARCH – Your Responsive CRO
MPI Research, with global headquarters in Mattawan, Michigan, provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. Responsiveness, scientific knowledge, and experience, integrity, trust, teamwork, and dedication to strong and enduring sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization.

Our open and responsive culture is evident in the collegial, collaborative atmosphere at MPI Research. Sponsors find communication with their counterparts within the company to be refreshingly easy, frequent, and informative. Study Directors are uniquely accessible on a real-time basis and proactive in keeping you informed as developments unfold, from collaboration on the initial program design through final report.

Website
www.mpiresearch.com

Services Provided:

Analytical Services
Bioanalytical testing
Chemistry & stability
Microbiology

Formulation Development & Phase I/II Clinical Trial Materials (CTM)
Active Pharmaceutical Ingredients (API) – small molecule

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here